Avicenna Alliance at IMDRF 2024 in Washington DC

As an observer to IMDRF, the Avicenna Alliance was invited to attend the open sessions and network with Regulatory Authorities, WHO, Trade Organizations, and Industry Representatives from around the world.

The focus of this session was good reliance practices among regulatory authorities and striking the balance between leveraging work undertaken by other regulatory bodies while maintaining sovereignty over regulatory decisions in individual jurisdictions. This discussion is an important step towards global harmonization. Highlighted in the panel discussions were the themes of protecting the safety of people within your jurisdiction, enabling the rapid and timely access to innovative technologies, and the dream of one day approval in one jurisdiction would mean approval in all jurisdictions.

At the Washington DC meeting, Mark Palmer was joined by Tina Morrison (FDA) and Jithesh Veetil (MDIC), among many others. We participated in a variety of discussions including rapid advances in modeling and simulation making it more applicable to the pharmaceutical and medical device industries, digital health initiatives in various jurisdictions, and the role of trade organizations in helping to drive modeling and simulation as a priority regulatory theme.